Epigallocatechin-3-gallate mobilizes intracellular Ca2+ in prostate cancer cells through combined Ca2+ entry and Ca2+-induced Ca2+ release
- PMID: 32781066
- DOI: 10.1016/j.lfs.2020.118232
Epigallocatechin-3-gallate mobilizes intracellular Ca2+ in prostate cancer cells through combined Ca2+ entry and Ca2+-induced Ca2+ release
Abstract
Aims: To elucidate the mechanism by which (-)-epigallocatechin-3-gallate (EGCG) mediates intracellular Ca2+ increase in androgen-independent prostate cancer (PCa) cells.
Main methods: Following exposure to different doses of EGCG, viability of DU145 and PC3 PCa cells was evaluated by MTT assay and the intracellular Ca2+ dynamics by the fluorescent Ca2+ chelator Fura-2. The expression of different channels was investigated by qPCR analysis and sulfhydryl bonds by Ellman's assay.
Key findings: EGCG inhibited DU145 and PC3 proliferation with IC50 = 46 and 56 μM, respectively, and induced dose-dependent peaks of internal Ca2+ that were dependent on extracellular Ca2+. The expression of TRPC4 and TRPC6 channels was revealed by qPCR in PC3 cells, but lack of effect by modulators and blockers ruled out an exclusive role for these, as well as for voltage-dependent T-type Ca2+ channels. Application of dithiothreitol and catalase and sulfhydryl (SH) measurements showed that EGCG-induced Ca2+ rise depends on SH oxidation, while the effect of EGTA, dantrolene, and the PLC inhibitor U73122 suggested that EGCG-induced Ca2+ influx acts as a trigger for Ca2+-induced Ca2+ release, involving both ryanodine and IP3 receptors. Different from EGCG, ATP caused a rapid Ca2+ increase, which was independent of external Ca2+, but sensitive to U73122.
Significance: EGCG induces an internal Ca2+ increase in PCa cells by a multi-step mechanism. As dysregulation of cytosolic Ca2+ is directly linked to apoptosis in PCa cells, these data confirm the possibility of using EGCG as a synergistic adjuvant in combined therapies for recalcitrant malignancies like androgen-independent PCa.
Keywords: ATP-induced Ca(2+) release; Androgen-resistant prostate cancer cells; Ca(2+)-induced Ca(2+) release; Cytotoxicity; DU145 cells; Fura2; Green tea; PC3 cells; SH oxidation.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
(-)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells.Clin Exp Pharmacol Physiol. 2004 Aug;31(8):530-6. doi: 10.1111/j.1440-1681.2004.04044.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15298546
-
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.Toxicol Appl Pharmacol. 2000 Apr 1;164(1):82-90. doi: 10.1006/taap.1999.8885. Toxicol Appl Pharmacol. 2000. PMID: 10739747
-
Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.J Cell Mol Med. 2012 Nov;16(11):2667-78. doi: 10.1111/j.1582-4934.2012.01584.x. J Cell Mol Med. 2012. PMID: 22564432 Free PMC article.
-
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.Biochem Pharmacol. 2000 Oct 15;60(8):1051-9. doi: 10.1016/s0006-2952(00)00385-3. Biochem Pharmacol. 2000. PMID: 11007941 Review.
-
Molecular targets for green tea in prostate cancer prevention.J Nutr. 2003 Jul;133(7 Suppl):2417S-2424S. doi: 10.1093/jn/133.7.2417S. J Nutr. 2003. PMID: 12840218 Review.
Cited by
-
IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.Front Endocrinol (Lausanne). 2021 Nov 1;12:763349. doi: 10.3389/fendo.2021.763349. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34790172 Free PMC article.
-
Epigallocatechin 3-gallate inhibits the plasma membrane Ca2+-ATPase: effects on calcium homeostasis.Heliyon. 2021 Feb 26;7(2):e06337. doi: 10.1016/j.heliyon.2021.e06337. eCollection 2021 Feb. Heliyon. 2021. PMID: 33681501 Free PMC article.
-
A Comprehensive Review on Beneficial Effects of Catechins on Secondary Mitochondrial Diseases.Int J Mol Sci. 2022 Sep 30;23(19):11569. doi: 10.3390/ijms231911569. Int J Mol Sci. 2022. PMID: 36232871 Free PMC article. Review.
-
Prostate cancer: Therapeutic prospect with herbal medicine.Curr Res Pharmacol Drug Discov. 2021 Jul 8;2:100034. doi: 10.1016/j.crphar.2021.100034. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909665 Free PMC article. Review.
-
Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies.Cancers (Basel). 2024 Aug 6;16(16):2777. doi: 10.3390/cancers16162777. Cancers (Basel). 2024. PMID: 39199550 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous